Related Experiment Video
Updated: May 21, 2025
Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells
Published on: June 16, 2019
Methodology for Assessing Drug Efficacy: Protocol for Single and Combination Drug Screening Using HeLa Cell Cultures
Phumuzile Dube1,2, Bernice Monchusi1,3, Mutsa M Takundwa1,2
1Synthetic Nanobiotechnology and Biomachines, Synthetic Biology and Precision Medicine Centre, Future Production Chemicals Cluster, Council for Scientific and Industrial Research, Pretoria, South Africa.
Abstract:
This protocol outlines a detailed method for performing drug sensitivity testing (DST) on HeLa cells, focusing on both single-drug and combination-drug screening to assess cell viability. DST is integral to cancer research and functional precision medicine, providing insight into individual drug responses and facilitating the optimization of drug combinations. The protocol includes preparing and maintaining HeLa cell cultures, seeding in 96-well plates, and performing single and combination drug treatments using a low-throughput screening approach. These drug treatments aim to evaluate therapeutic effectiveness, enhance understanding of synergistic interactions, and identify optimal combinations that could minimize toxicity while overcoming resistance. Data analysis uses open-source tools, including the BREEZE pipeline and Synergy-Finder, allowing for precise analysis of cell viability and drug interactions. This protocol provides a robust, reproducible framework for DST in cancer research, applicable to other cell lines, patient samples, and various drug types/classes. The critical role of DST in improving clinical treatment strategies through precise, scalable drug response analysis is demonstrated.
Insights
This study details a drug sensitivity testing (DST) protocol for HeLa cells, evaluating single and combination drug effectiveness for cancer research and precision medicine. The method optimizes drug combinations to improve therapeutic outcomes and reduce toxicity.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Drug sensitivity testing (DST) is crucial for cancer research and functional precision medicine.
- Understanding individual drug responses and optimizing drug combinations are key to effective cancer therapy.
- Existing methods may require refinement for scalability and precise analysis of drug interactions.
Purpose of the Study:
- To establish a detailed protocol for drug sensitivity testing (DST) on HeLa cells.
- To evaluate both single-drug and combination-drug screening for assessing cell viability.
- To provide a framework for identifying optimal drug combinations with minimized toxicity and enhanced efficacy.
Main Methods:
- Preparation and maintenance of HeLa cell cultures.
- Seeding cells in 96-well plates for low-throughput screening.
- Performing single and combination drug treatments, followed by cell viability assessment.
- Utilizing open-source tools like BREEZE and Synergy-Finder for data analysis.
Main Results:
- The protocol enables precise analysis of cell viability in response to various drug treatments.
- It facilitates the evaluation of synergistic interactions between drug combinations.
- The method demonstrates scalability and reproducibility for DST applications.
Conclusions:
- This robust DST protocol offers a reproducible framework for cancer research.
- It is applicable to diverse cell lines, patient samples, and drug types.
- The protocol supports the development of improved clinical treatment strategies through precise drug response analysis.
More Related Videos
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
00:12A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
Published on: September 22, 2019